Emanuele Zucca

Research interests

Publications

• Genomic profiling for clinical decision making in lymphoid neoplasms

  Blood · 2022 · https://doi.org/10.1182/blood.2022015854

• The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

  Blood · 2022 · https://doi.org/10.1182/blood.2022015851

• Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2019.10.010

• Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

  Blood · 2018 · https://doi.org/10.1182/blood-2017-11-812073

• Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

  The Lancet Haematology · 2017 · https://doi.org/10.1016/s2352-3026(17)30174-6

• Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

  The Lancet Haematology · 2016 · https://doi.org/10.1016/s2352-3026(16)00036-3

• Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

  The Lancet Haematology · 2016 · https://doi.org/10.1016/s2352-3026(16)00021-1

• Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

  Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1335

• The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

  Clinical Cancer Research · 2015 · https://doi.org/10.1158/1078-0432.ccr-14-1561

• Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.53.5229

• Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.54.8800

• ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mds643

• Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

  Blood · 2013 · https://doi.org/10.1182/blood-2013-03-489518

• ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

  Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds517

• Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

  Blood · 2010 · https://doi.org/10.1182/blood-2010-01-264275

• Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

  Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-3266

• High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

  The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61416-1

• Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.08.2313

• Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

  Annals of Oncology · 2007 · https://doi.org/10.1093/annonc/mdm471

• Revised Response Criteria for Malignant Lymphoma

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.09.2403

• Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.08.128

• Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

  British Journal of Haematology · 2005 · https://doi.org/10.1111/j.1365-2141.2005.05883.x

• Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.13.524

• Follicular lymphoma international prognostic index.

  PubMed · 2004 · https://doi.org/10.1182/blood-2003-12-4434

• Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1

  British Journal of Haematology · 2004 · https://doi.org/10.1111/j.1365-2141.2004.05177.x

• Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

  Blood · 2003 · https://doi.org/10.1182/blood-2002-04-1279

• Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

  Journal of Clinical Oncology · 2003 · 10.1200/jco.2003.09.139

• Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

  Journal of Clinical Oncology · 2002 · https://doi.org/10.1200/jco.2003.11.141

• Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas

  Annals of Oncology · 1997 · https://doi.org/10.1023/a:1008282818705

Current projects

No projects listed.